HVA and HMMA/VMA
Clinical Biochemistry
Sample and container requirements
Plain Spot Urine
Minimum volume required
1 mL urine
Special requirements
Adjust pH to 3.0 - 3.5 on receipt in the laboratory.
Patient preparation
None
Sample viability
Turnaround time
2 days
Reference range
HVA: Infant: 4 – 25 µmol/mmol creatinine 1 – 5 years: 2 – 15 µmol/mmol creatinine >5 years: 2 – 13 µmol/mmol creatinine HMMA/VMA: Infant: 2 – 12 µmol/mmol creatinine 1 year – 5 years: 2 – 9 µmol/mmol creatinine > 5 years: 1 – 7 µmol/mmol creatinine
Clinical guidance
Neuroblastoma is a neoplastic disease of infants and early childhood and is the third most common malignant cancer tumours in paediatric patients. Approximately 80% are found in children under 5 years of age. Elevated values of homovanillic acid (HVA, a metabolite of dopamine) and HMMA/VMA (a metabolite of metadrenalines), may be suggestive of the presence of neuroblastoma. HVA and HMMA/VMA can be used for the diagnosis and follow up treatment of neuroblastoma.
Notes
Please contact the Duty Biochemist on 0121 424 1392 (or bleep 2506) prior to sending samples for this test.
Images to go here
This information was last updated on 19 August 2026